Antibiotic Treatment for Infected Epidermal Inclusion Cysts

Primary Management Approach

Incision and drainage is the recommended first-line treatment for inflamed epidermal inclusion cysts, as suggested by the Infectious Diseases Society of America 1, 2, 3
Most cases can be managed without antibiotics if there are no systemic signs of infection, according to the Infectious Diseases Society of America 1, 2

Antibiotics should be considered as an adjunct to incision and drainage when a patient shows signs of systemic inflammatory response syndrome (SIRS), including temperature >38°C or <36°C, tachypnea >24 breaths per minute, tachycardia >90 beats per minute, or white blood cell count >12,000 or <400 cells/µL, as recommended by the Infectious Diseases Society of America 1, 2, 3
Patient has markedly impaired host defenses, as suggested by the Infectious Diseases Society of America 1

When antibiotics are indicated, they should target Staphylococcus aureus as the most likely pathogen, with first-line options including dicloxacillin or other penicillinase-resistant penicillins, cephalexin or other first-generation cephalosporins, as recommended by the Infectious Diseases Society of America and the European Society of Clinical Microbiology and Infectious Diseases 1, 4, 5
For penicillin-allergic patients or suspected MRSA, clindamycin, trimethoprim-sulfamethoxazole (SMX-TMP), or doxycycline may be considered, as suggested by the Infectious Diseases Society of America and the European Society of Clinical Microbiology and Infectious Diseases 1, 4, 5

For severe infections with systemic illness, consider broader coverage until culture results are available, as recommended by the Infectious Diseases Society of America 2
In areas with high MRSA prevalence, empiric coverage should include MRSA-active agents, as suggested by the European Society of Clinical Microbiology and Infectious Diseases 4, 5
Duration of therapy is typically 5-7 days, but may be extended based on clinical response, as recommended by the Infectious Diseases Society of America 6

Treating with antibiotics alone without performing incision and drainage, as cautioned by the Infectious Diseases Society of America 1, 2
Prescribing antibiotics for all infected cysts regardless of systemic symptoms, as cautioned by the Infectious Diseases Society of America and the World Society of Emergency Surgery 1, 7
Failing to consider MRSA coverage in areas with high prevalence, as cautioned by the European Society of Clinical Microbiology and Infectious Diseases 4, 5

Antibiotics are recommended when there is significant surrounding cellulitis that extends beyond the borders of the abscess. 8
Antibiotics are also indicated when source control after drainage is incomplete, such as residual purulent material or failure to fully evacuate the cyst cavity. 8

In regions where MRSA prevalence is ≥10 % or MRSA infection is suspected, the preferred oral agents are trimethoprim‑sulfamethoxazole, doxycycline, or clindamycin (provided local clindamycin resistance is <10 %). 9

Avoid TMP‑SMX monotherapy when streptococcal cellulitis is a possible diagnosis, because streptococci are intrinsically resistant to this drug. 10
For patients with an immediate‑type penicillin allergy (e.g., urticaria, angioedema, anaphylaxis), clindamycin, trimethoprim‑sulfamethoxazole, or doxycycline are appropriate alternative agents. 9

Linezolid should be reserved for severe infections or treatment failures, as it offers no proven superiority over less expensive alternatives and carries higher cost. 9